Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Sleep Quality Improvement a ‘Tremendous Opportunity’ in Treating GI Conditions
-
- 8 recent reports on diet’s protective, risk-increasing effects on liver health
- Oral S1P receptor modulator etrasimod shows benefits in severe UC
- Perrigo launches oral dissolving PPI for heartburn
- Stem cell therapy approved in Europe to treat fistulizing Crohn’s disease
- International Liver Congress Offers Insight on the ‘Social Science’ of HCV Ira M. Jacobson, MD
- New ACG Crohn’s guideline reflects ‘cross-fertilization’ of knowledge
- Cannabinoid hyperemesis syndrome: What GIs should know
- Common diabetes medication may increase IBD risk
-
- Diet, lifestyle outweigh genetic impact on gut microbiome
- Mediterranean diet reduces liver fat, risk for NAFLD
- $300 HCV combination reaches 97% cure rates in Malaysia, Thailand
- Bariatric surgery patients at risk for opioid addiction
- Cenicriviroc shows safe long-term antifibrotic activity in adults with NASH
- ELAD shows promise in alcoholic hepatitis biomechanical response
- Fecal microbiota transplant improves brain function in hepatic encephalopathy
- Galectin-3 inhibitor improves hepatic ballooning in NASH
-
- Givosiran reduces neurotoxic intermediates in acute hepatic porphyrias
- Low food security increases risk for advanced fibrosis
- Social media offers feasible platform for CME
- Thyroid receptor agonist for 12 weeks reduces hepatic fat in NASH
- 4 ways to address the #MeToo era in health care
- Swallowable test developed for Barrett’s esophagus
- Colonoscopy may be associated with appendicitis